NCT06383663View on ClinicalTrials.gov

Supraclavicular Lymph Node Dissection for Ipsilateral Supraclavicular Lymph Node Metastatic Breast Cancer

NANot yet recruitingINTERVENTIONAL

Enrollment

452

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions

Breast CancerIpsilateral Supraclavicular Lymph Node Metastasis

Interventions

PROCEDURE

Supraclavicular lymph node dissection combined with radiotherapy

Breast cancer patients in the expreimental cohort with only ipsilateral supraclavicular lymph node metastasis were first treated with supraclavicular lymph node dissection and received standard radiotherapy after surgery.

RADIATION

radiotherapy

Patients in the control group received only standard radiation therapy.

All Listed Sponsors

lead

Sun Yat-sen University

OTHER

NCT06383663 - Supraclavicular Lymph Node Dissection for Ipsilateral Supraclavicular Lymph Node Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter